Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ria

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Orphanet Journal of Rare Diseases|May 15, 2026
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe diseaseAlberto Lerario, Elena Abati, Monica Sciacco, et al.
Oncotarget|February 27, 2016
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patientsAurelia Lamanuzzi, Ilaria Saltarella, Arianna Ferrucci, et al.
Angiogenesis|July 25, 2013
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myelomaAnnunziata De Luisi, Laura Binetti, Roberto Ria, et al.
Allergy|June 25, 2025
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective StudiesFederico Spataro, Fabio Cacciapaglia, Palma Carlucci, et al.
Ocular Immunology and Inflammation|July 16, 2021
The Spectrum of Ocular Manifestations in Patients with Waldenström's MacroglobulinemiaRosanna Dammacco, Walter Lisch, Tero T Kivelä, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2023
Recommendations for Management of Secondary Antibody Deficiency in Multiple MyelomaSergio Giralt, Stephen Jolles, Tessa Kerre, et al.
Journal of Clinical Medicine|February 23, 2020
Bortezomib Treatment Modulates Autophagy in Multiple MyelomaGiuseppe Di Lernia, Patrizia Leone, Antonio Giovanni Solimando, et al.
Blood|July 18, 2015
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killingPatrizia Leone, Simona Berardi, Maria Antonia Frassanito, et al.
Cells|January 16, 2020
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple MyelomaIlaria Saltarella, Vanessa Desantis, Assunta Melaccio, et al.
Clinical and Experimental Medicine|September 20, 2011
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphomaFranca Falzetti, Mauro Di Ianni, Stelvio Ballanti, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Orphanet Journal of Rare Diseases|May 15, 2026
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe diseaseAlberto Lerario, Elena Abati, Monica Sciacco, et al.
Oncotarget|February 27, 2016
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patientsAurelia Lamanuzzi, Ilaria Saltarella, Arianna Ferrucci, et al.
Angiogenesis|July 25, 2013
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myelomaAnnunziata De Luisi, Laura Binetti, Roberto Ria, et al.
Allergy|June 25, 2025
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective StudiesFederico Spataro, Fabio Cacciapaglia, Palma Carlucci, et al.
Ocular Immunology and Inflammation|July 16, 2021
The Spectrum of Ocular Manifestations in Patients with Waldenström's MacroglobulinemiaRosanna Dammacco, Walter Lisch, Tero T Kivelä, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2023
Recommendations for Management of Secondary Antibody Deficiency in Multiple MyelomaSergio Giralt, Stephen Jolles, Tessa Kerre, et al.
Journal of Clinical Medicine|February 23, 2020
Bortezomib Treatment Modulates Autophagy in Multiple MyelomaGiuseppe Di Lernia, Patrizia Leone, Antonio Giovanni Solimando, et al.
Blood|July 18, 2015
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killingPatrizia Leone, Simona Berardi, Maria Antonia Frassanito, et al.
Cells|January 16, 2020
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple MyelomaIlaria Saltarella, Vanessa Desantis, Assunta Melaccio, et al.
Clinical and Experimental Medicine|September 20, 2011
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphomaFranca Falzetti, Mauro Di Ianni, Stelvio Ballanti, et al.
Pageof 14